Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptid
Kurzübersicht für Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptid (ABIN8113274)
Target
Quelle
Applikation
-
-
Verwendungszweck
- SSX2IP Peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-SSX2IP antibody ( ARP53690_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
-
Hintergrund
-
Background Information: SSX2IP belongs to an adhesion system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs). It may connect the nectin-afadin and E-cadherin-catenin system through alpha-actinin and may be involved in organization of the actin cytoskeleton at AJs through afadin and alpha-actinin.
Alternative Symbols: ADIP, FLJ10848, KIAA0923, MGC75026
-
Molekulargewicht
- 68kDa
-
Gen-ID
- 117178
-
NCBI Accession
- NP_054740
-
UniProt
- Q9Y2D8
Target
-